These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36057660)
1. Computed tomography texture analysis for the prediction of lateral pelvic lymph node metastasis of rectal cancer. Nakao T; Shimada M; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Takasu C; Wada Y; Yoshimoto T World J Surg Oncol; 2022 Sep; 20(1):281. PubMed ID: 36057660 [TBL] [Abstract][Full Text] [Related]
2. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer. Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145 [TBL] [Abstract][Full Text] [Related]
3. Lateral pelvic sentinel lymph node biopsy using indocyanine green fluorescence navigation: can it be a powerful supplement tool for predicting the status of lateral pelvic lymph nodes in advanced lower rectal cancer. Su H; Xu Z; Bao M; Luo S; Liang J; Pei W; Guan X; Liu Z; Jiang Z; Zhang M; Zhao Z; Jin W; Zhou H Surg Endosc; 2023 May; 37(5):4088-4096. PubMed ID: 36997652 [TBL] [Abstract][Full Text] [Related]
4. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer. Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366 [TBL] [Abstract][Full Text] [Related]
5. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer. Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628 [TBL] [Abstract][Full Text] [Related]
6. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer. Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167 [TBL] [Abstract][Full Text] [Related]
7. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings. Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321 [TBL] [Abstract][Full Text] [Related]
8. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes? Ahmadi N; Brown KGM; Lee P; Quinn M; Austin KKS; Solomon MJ Colorectal Dis; 2020 Jun; 22(6):689-693. PubMed ID: 31909851 [TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of lateral pelvic sentinel lymph node biopsy using indocyanine green fluorescence navigation in laparoscopic lateral pelvic lymph node dissection]. Su H; Xu Z; Bao MDL; Luo S; Liang JW; Pei W; Guan X; Liu Z; Jiang Z; Zhang MG; Zhao ZX; Jin WS; Zhou HT Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):140-145. PubMed ID: 38418188 [No Abstract] [Full Text] [Related]
10. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT). Peacock O; Manisundaram N; Dibrito SR; Kim Y; Hu CY; Bednarski BK; Konishi T; Stanietzky N; Vikram R; Kaur H; Taggart MW; Dasari A; Holliday EB; You YN; Chang GJ Ann Surg; 2022 Oct; 276(4):654-664. PubMed ID: 35837891 [TBL] [Abstract][Full Text] [Related]
11. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer. Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224 [TBL] [Abstract][Full Text] [Related]
12. Lateral pelvic lymph node positivity (LPLNP) score: predictive clinic-radiological model of lateral pelvic lymph node involvement in rectal cancer patients. Tsarkov P; Balaban V; Babajanyan H; Fingerhut A; Tulina I; He M Int J Colorectal Dis; 2024 Sep; 39(1):145. PubMed ID: 39292276 [TBL] [Abstract][Full Text] [Related]
13. MRI-based Radiomics Model for Preoperative Prediction of Lateral Pelvic Lymph Node Metastasis in Locally Advanced Rectal Cancer. Zhao W; Xu H; Zhao R; Zhou S; Mei S; Wang Z; Zhao F; Xiao T; Huang F; Qiu W; Tang J; Liu Q Acad Radiol; 2024 Jul; 31(7):2753-2772. PubMed ID: 37643928 [TBL] [Abstract][Full Text] [Related]
14. Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum. Ogawa S; Hida JI; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Yamamoto M; Sugihara K; Watanabe T Int J Colorectal Dis; 2017 Oct; 32(10):1479-1487. PubMed ID: 28762189 [TBL] [Abstract][Full Text] [Related]
15. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer. Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959 [TBL] [Abstract][Full Text] [Related]
16. Selection of Lymph Node-Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum. Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Kameoka S; Sugihara K Ann Surg Oncol; 2016 Apr; 23(4):1187-94. PubMed ID: 26671038 [TBL] [Abstract][Full Text] [Related]
17. Dual energy CT is useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer. Sato K; Morohashi H; Tsushima F; Sakamoto Y; Miura T; Fujita H; Umemura K; Suzuki T; Tsuruta S; Kura R; Ono S; Aoki M; Hakamada K Mol Clin Oncol; 2019 Jun; 10(6):625-630. PubMed ID: 31031979 [TBL] [Abstract][Full Text] [Related]
18. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI. Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955 [TBL] [Abstract][Full Text] [Related]
19. Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer. Fujita S; Yamamoto S; Akasu T; Moriya Y Int J Colorectal Dis; 2009 Sep; 24(9):1085-90. PubMed ID: 19387660 [TBL] [Abstract][Full Text] [Related]
20. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum. Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]